Max Zeller Söhne AG Switzerland

Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability. 

Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.

 

Website:
www.zellerag.com
Dr Si Chen
Dr Si Chen
LinkedIn logo Business Development Manager 
Ms Yulia Kirschner
Ms Yulia Kirschner
LinkedIn logo Director International Division 

Lupin Atlantis Holdings SA Switzerland

Dr sandra single
Senior Director BD 

Fair-Med Healthcare AG Switzerland

Mr Oren Weininger
CEO 
Dr Oren Weininger
CEO 

Debiopharm International SA Switzerland

Dr Fabien Sebille
Director Business Development, Licensing Marketing & Communication 
Dr Fabrice Paradies
Director Industrial Business Develpment & Global Commercial Alliances 

Medinova AG Switzerland

Mr Frank Buennig
Managing Director 

Vifor Pharma Switzerland

Mrs Gabrielle Gache
Head BD&L Switzerland 
Dr Roland Pfeiffer
Head of Commercial Development Europe 

PMC Pharma Management Consultants GmbH Switzerland

Mergers & Acquisitions

We are a deal broker and M&A advisory boutique that is specializing in transactions in the corporate sector of the pharmaceutical and healthcare industry and the consumer goods industry.

We support our clients in

  • Purchase and sale of companies and participations
  • Purchase and sale of brands and product portfolios
  • Business cooperations

We carry out targeted searches for transaction opportunities worldwide and support our clients in all phases of the M&A process.

Due to our long experience in this field and our continuously updated network of more than 40,000 strategic and financial investors worldwide we are able to quickly identify suitable investors and/or targets and complete transactions discreetly and reliably.

Dr Marc Raber
Dr Marc Raber
Managing Director 
Mr Sascha Raber
Mr Sascha Raber
M&A Advisor